Personal information
Chavakis, Triantafyllos, Prof. Dr. med.
Institute for Clinical Chemistry and Laboratory Medicine
University Hospital Carl Gustav Carus, TUD
Current position
Professor of Clinical Chemistry and Clinical Pathobiochemistry, Director Institute for Clinical Chemistry and Laboratory Medicine (since 2017)
Role within partner site
Research on innate immunity and immunometabolism
Relevant work experience
Immunologist with focus on trained innate immunity
2019-22 MPI-CBG-Fellow, MPI-CBG Dresden
2019-22 Visiting Professor, Centre for Cardiovascular Science, Queen’s Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, UK
2018- Faculty Member, National Center for Tumor Diseases, Partner Site Dresden of the German Cancer Research Center, Heidelberg
2017- Professor & Director Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, TUD
2014-17 Professor & Head, Department of Clinical Pathobiochemistry at the Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, TUD
2011- Faculty Member, Paul Langerhans Institute for Diabetes Research, Dresden of the Helmholtz Center Munich and German Center for Diabetes Research
2010-14 Professor Medical Clinic I, University Hospital Carl Gustav Carus, TUD
Professional background
2001 Doctorate (Dr. med.), Justus-Liebig-Universität Giessen
1993-00 Studies in Human Medicine, Justus-Liebig-Universität Giessen
Main research focus
Inflammatory diseases, metabolic diseases, innate immunity, immunometabolism
Publications
5 out of 232; SCOPUS h-index 62* equal authorship
Kourtzelis I, …, Hajishengallis G*, Chavakis T*. DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nat Immunol 2019;20:40-9.
Chavakis T*, Mitroulis I*, Hajishengallis G*. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat Immunol 2019;20:802-11.
Mitroulis I, …, Hajishengallis G*, Netea MG*, Chavakis T*. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 2018;72:147-61. (~200 citations)
Chung KJ, …, Chavakis T. A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity. Nat Immunol 2017;18:654-64.
Choi EY, …, Chavakis T. Del-1, an endogenous leukocyte endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008;322:1101-04.
Additional information
ERC-Grant (2017-2021); R. Koselleck Grant of the DFG (2011-2017)
ERC-Grant (2011-2016)
European Society for Clinical Investigation Award for Excellence in Translational Research (2012)
